TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2026
Back to search
Official data from USPTO
BSC TARGET A CURE. BIOLOGICAL SPECIALTYCOMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/07/2026
Trademark type
Combined
Nice classes
44
Filing date
07/31/2019
Registration date
12/31/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2025
Last transaction
06/07/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/31/2019
First use in commerce
07/31/2019
Drawing code
3
Owner type
16
Owner location
Westbury, NY, US
Examiner
SEGAL, MOLLY DANIELA
Current location
Historical data usage
Mark description
The mark consists of a design of a design of a red blood drop on a white circular background surrounded by two rings of contrasting shades of red; the letters "BSC" in upper case black type appear to the right of the circular design; the wording "TARGET A CURE" followed by a period appears in red upper and lower case lettering underneath "BSC"; a vertical red line appears to the right of "BSC" and "TARGET A CURE"; the wording "BIOLOGICAL SPECIALTY COMPANY" appears in black lower case letters in column form to the right of the red vertical line.
Holders and representatives
Holders
BioIVT Holdings, LLC
BioIVT Holdings, LLC
Representatives
Chun T. Wright Law Office of Chun T. Wright, PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
collecting and preserving donations of blood and other biofluids from consented donors for use in scientific and medical research
Publications
History of USPTO decisions and trademark events.
30 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/19/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/12/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/17/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/31/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/27/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/27/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/27/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/27/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2019
PUBO
PUBLISHED FOR OPPOSITION
10/15/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2019
ALIE
ASSIGNED TO LIE
09/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2019
DOCK
ASSIGNED TO EXAMINER
08/20/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2019
NWAP
NEW APPLICATION ENTERED
08/03/2019
Continuous trademark protection
Get notified about every new filing that threatens BSC TARGET A CURE. BIOLOGICAL SPECIALTYCOMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.